DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Avience Biomedicals Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·23 Sept 2026, 9:36 am

Avience Biomedicals

Avience Biomedicals Limited has announced that it will be holding an analyst or institutional investor meet, where the company’s management is expected to discuss its business strategy and future outlook. This event is scheduled for a specific date, as communicated to the stock exchange, and is intended to provide clarity on the company's operational plans.

For investors, such meetings are valuable because they offer insights into management’s thinking and upcoming initiatives. This information can help retail investors better understand the company's direction and assess its growth potential.

What to watch next is the official transcript or summary of the meeting, which will be made available on the company’s website. Investors should pay attention to management's commentary on their financial targets and product pipeline.